The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s lewy body dementia treatment market report forecasts the lewy body dementia treatment market size to grow to $5.2 Billion by 2027, with a CAGR (compound annual growth rate) of more than 5%.

Learn More On The Lewy Body Dementia Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/lewy-body-dementia-treatment-global-market-report

Lewy Body Dementia Treatment Market Size Forecast
The global lewy body dementia treatment market is expected to grow from $3.90 billion in 2022 to $4.16 billion in 2023 at a compound annual growth rate (CAGR) of 6.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global lewy body dementia treatment market size is expected to reach $5.2 billion in 2027 at a CAGR of 5.7%.

North America held the largest lewy body dementia treatment market share.

Key Lewy Body Dementia Treatment Market Driver ­– Rise In The Prevalence Of Brain-Related Disorders
According to a report issued in January 2022 by the American Heart Association Inc., a US-based nonprofit voluntary organisation, brain diseases are anticipated to increase to 9.3 million in the US by 2060, and this figure is now expanding in the US. A brain disorder affects one out of every six persons worldwide. By 2021, 1 billion people will be affected by brain illnesses worldwide. As a result, the increased prevalence of brain-related ailments is propelling the lewy body dementia therapy market forward.

Request for A Sample Of The Global Lewy Body Dementia Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9387&type=smp

Key Lewy Body Dementia Treatment Market Trend – Product Innovation
Major players in the lewy body dementia treatment market are focusing on providing unique solutions to increase their market position. For example, Biogen Inc., a multinational biotechnology corporation based in the United States, produced lecanemab, a humanised monoclonal antibody, in January 2023. This medication is used to treat Alzheimer’s disease, which is a component of Lewy body dementia. The main advantage of lecanemab is that it lowers amyloid levels in the brain. It treats the brain and removes amyloid plaques, which are considered to cause cognitive impairment and dementia in Alzheimer’s disease.

Lewy Body Dementia Treatment Market Segment
1) By Drug Type: Antidepressants, Antipsychotic Drugs, Benzodiazepine, Carbidopa-Levodopa, Cholinesterase inhibitors, Modafinil
2) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
3) By Application: Alzheimer’s disease, Dementia, Parkinson’s disease

Lewy Body Dementia Treatment Market Major Players and Strategies
Major players in the lewy body dementia treatment market are Mallinckrodt Pharmaceuticals, BioArctic AB, Sumitomo Pharma Co. Ltd., Jazz Pharmaceuticals Inc., Allergan Plc., Noven Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Novartis AG, GSK Plc., Teva Pharmaceutical Industries Ltd., Bayer AG, Sanofi S.A., Mylan N.V., Bausch Health Companies Inc., Eisai Co. Ltd., and Pfizer Inc.

Pfizer Inc., a multinational pharmaceutical and biotechnology business based in the United States, paid $11.6 billion for Biohaven Pharmaceuticals Inc. in October 2022. Pfizer Inc. hopes to strengthen its ability to provide innovative treatment alternatives to patients and to expand its global market with this acquisition. Biohaven Pharmaceuticals Inc. is a pharmaceutical business established in the United States that develops medications to treat Parkinson’s disease, also known as lewy body dementia.

The Lewy Body Dementia Treatment Global Market Report 2023 covers regional data on lewy body dementia treatment market size, lewy body dementia treatment market trends and drivers, opportunities, strategies, and lewy body dementia treatment market competitor analysis. The countries covered in the lewy body dementia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Medication and nonmedical therapies, such as physical, occupational, and speech therapy, are used to manage symptoms as much as possible in people with Lewy body dementia. The treatment is used to repair and regulate some symptoms, as well as to lessen hallucinations, disorientation, tiredness, mobility issues, and disturbed sleep.

View More Reports Related To The Lewy Body Dementia Treatment Market –
Body Fat Reduction Global Market Report 2023
Brain Monitoring Global Market Report 2023
Microbiome Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: